Lupin Ltd

LUPIN

Company Profile

  • Business description

    Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.

  • Contact

    Off. Western Express Highway
    3rd floor, Kalpataru Inspire
    Santacruz (East)
    MumbaiMH400055
    IND

    T: +91 2266402323

    E: [email protected]

    https://www.lupin.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2025

    Employees

    19,862

Stocks News & Analysis

stocks

Our view of BHP after reporting sales volumes

First half results largely met our expectations.
stocks

The fight for Insignia continues

Numerous acquisition proposals vindicate Insignia's improved earnings momentum.
stocks

Trouble continues as Star Entertainment burns through cash

More pain in the horizon as the company struggles to stay afloat.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,629.1051.40-0.59%
CAC 407,892.6155.210.70%
DAX 4021,411.53157.260.74%
Dow JONES (US)44,438.60281.870.64%
FTSE 1008,565.2020.070.23%
HKSE19,700.5678.21-0.40%
NASDAQ19,929.2780.07-0.40%
Nikkei 22539,958.87312.620.79%
NZX 50 Index13,060.0822.940.18%
S&P 5006,091.915.540.09%
S&P/ASX 2008,378.7051.10-0.61%
SSE Composite Index3,230.1616.540.51%

Market Movers